Zobrazeno 1 - 10
of 29
pro vyhledávání: '"Ronny M. Schulz"'
Autor:
Marco Wallenborn, Li-Xin Xu, Holger Kirsten, Leili Rohani, Daniela Rudolf, Peter Ahnert, Christian Schmidt, Ronny M Schulz, Mandy Richter, Wolfgang Krupp, Wolf Mueller, Adiv A Johnson, Jürgen Meixensberger, Heidrun Holland
Publikováno v:
PLoS ONE, Vol 15, Iss 7, p e0234986 (2020)
Glioblastoma is a common, malignant brain tumor whose disease incidence increases with age. Glioblastoma stem-like cells (GSCs) are thought to contribute to cancer therapy resistance and to be responsible for tumor initiation, maintenance, and recurr
Externí odkaz:
https://doaj.org/article/49a74c104af148c38165885718938826
Autor:
Gabriela Aust, Gero Hütter, Ralf Henkelmann, Bastian Marquass, Ronny M. Schulz, Oliver Petters, Philipp Pieroh, Christian Schmidt
Publikováno v:
Stem Cells and Development. 27:545-555
Due to the limited self-healing capacity of articular cartilage, innovative, regenerative approaches are of particular interest. The use of two-stage procedures utilizing in vitro-expanded mesenchymal stromal cells (MSCs) from various cell sources re
Publikováno v:
Medizinrecht. 35:533-538
Autor:
Oliver, Petters, Christian, Schmidt, Ralf, Henkelmann, Philipp, Pieroh, Gero, Hütter, Bastian, Marquass, Gabriela, Aust, Ronny M, Schulz
Publikováno v:
Stem cells and development. 27(8)
Due to the limited self-healing capacity of articular cartilage, innovative, regenerative approaches are of particular interest. The use of two-stage procedures utilizing in vitro-expanded mesenchymal stromal cells (MSCs) from various cell sources re
Publikováno v:
Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz. 58:1215-1224
Bei der Entwicklung von Arzneimitteln sind vor der ersten Anwendung am Menschen Tiermodelle für den Nachweis der Wirksamkeit und Sicherheit nach wie vor unverzichtbar. Arzneimittel für neuartige Therapien (Advanced Therapy Medicinal Products, ATMP)
Autor:
Ronny M. Schulz, Christian B Thuemmler, Jeremy S. Somerson, Frank Peinemann, Christian Schmidt, Matthias Zscharnack, Oliver Petters
Publikováno v:
Journal of tissue engineering and regenerative medicine. 12(7)
Due to the poor self-healing capacities of cartilage, innovative approaches are a major clinical need. The use of in vitro expanded mesenchymal stromal cells (MSCs) in a 2-stage approach is accompanied by cost-, time-, and personnel-intensive good ma
Publikováno v:
Biomechanics and modeling in mechanobiology. 16(4)
Most current cartilage testing devices require the preparation of excised samples and therefore do not allow intra-operative application for diagnostic purposes. The gold standard during open or arthroscopic surgery is still the subjective perception
Autor:
Jeremy S. Somerson, J Mochida, Thomas Aigner, M Schöne, B Marquaß, Nils Männicke, R Henkelmann, Kay Raum, Ronny M. Schulz
Publikováno v:
European Cells & Materials, Vol 31, Pp 119-135 (2016)
Objective and sensitive assessment of cartilage repair outcomes lacks suitable methods. This study investigated the feasibility of 3D ultrasound biomicroscopy (UBM) to quantify cartilage repair outcomes volumetrically and their correlation with estab
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7e58d17ca5373d40616bc371a14a7fc4
http://www.ecmjournal.org/journal/papers/vol031/vol031a09.php
http://www.ecmjournal.org/journal/papers/vol031/vol031a09.php
Autor:
Christoph Josten, Thomas Aigner, Jeremy S. Somerson, Pierre Hepp, Augustinus Bader, Robert Richter, Matthias Zscharnack, Bastian Marquass, Ronny M. Schulz
Publikováno v:
The American Journal of Sports Medicine. 38:1857-1869
Background: The use of mesenchymal stem cells (MSCs) to treat osteochondral defects caused by sports injuries or disease is of particular interest. However, there is a lack of studies in large-animal models examining the benefits of chondrogenic pred
Autor:
Matthias Zscharnack, Christoph Josten, Thomas Aigner, Ronny M. Schulz, Bastian Marquass, Pierre Hepp, Augustinus Bader, Stefan Schwan, Jeremy S. Somerson
Publikováno v:
Journal of Orthopaedic Research. 28:1586-1599
Mesenchymal stem cells (MSC) are increasingly replacing chondrocytes in tissue engineering based research for treatment of osteochondral defects. The aim of this work was to determine whether repair of critical-size chronic osteochondral defects in a